Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
about
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced diseaseSecond or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced diseaseVinorelbine-related cardiac events: a meta-analysis of randomized clinical trials.Oral versus intravenous vinorelbine: clinical safety profile.Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients.Drug target interaction of tubulin-binding drugs in cancer therapy.
P2860
Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Vinorelbine plus cisplatin ver ...... prospective randomized study.
@ast
Vinorelbine plus cisplatin ver ...... prospective randomized study.
@en
type
label
Vinorelbine plus cisplatin ver ...... prospective randomized study.
@ast
Vinorelbine plus cisplatin ver ...... prospective randomized study.
@en
prefLabel
Vinorelbine plus cisplatin ver ...... prospective randomized study.
@ast
Vinorelbine plus cisplatin ver ...... prospective randomized study.
@en
P2093
P1433
P1476
Vinorelbine plus cisplatin ver ...... prospective randomized study.
@en
P2093
Domenico Galetta
Ernesto Durini
Fernando Riccardi
Giuseppe Colucci
Giuseppe Pezzella
Gruppo Oncologico Italia Meridionale
Matteo Valdesi
Michele Caruso
Nicolò Borsellino
Nicolò Gebbia
P304
P356
10.1016/S0169-5002(02)00076-4
P577
2002-08-01T00:00:00Z